Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 43: 1965-1974, 1997;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (52)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kropf, J.
Right arrow Articles by Gressner, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kropf, J.
Right arrow Articles by Gressner, A. M.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1997;43:1965-1974.)
© 1997 American Association for Clinical Chemistry, Inc.


Articles

Immunological measurement of transforming growth factor-beta 1 (TGF-ß1) in blood; assay development and comparison

Jürgen Kropfa, Josef O. Schurek, Antje Wollner and Axel M. Gressner

Department of Clinical Chemistry and Central Laboratory, Philipps University, Marburg, Germany.
a Address for correspondence. Abteilung für Klinische Chemie und Zentrallaboratorium, Klinikum der Philipps-Universität, Baldingerstraße, 35033 Marburg, Germany. Fax (+49) 6421 28 5594; e-mail kropf{at}mailer.uni-marburg.de and www.med.uni-marburg.de/labmed.

Development of a new, sensitive immunoassay for measuring transforming growth factor beta 1 (TGF-ß1) is described and compared with four commercially available TGF-ß1 immunoassays. Preanalytical conditions were evaluated. The nonlinearity found in serum or plasma is due to masking of TGF-ß1 by binding proteins in blood. Mixing TGF-ß1 with latency-associated peptide or {alpha}2-macroglobulin at physiological concentrations suppressed most of the TGF-ß1 signal. Plasma fibronectin showed no effect, even at concentrations exceeding its physiological range. Equilibrium concentrations computed from a model system confirmed the experimental results. Dilutional nonlinearity could be markedly reduced by an appropriately designed activation procedure that minimized the effects of reassociation between TGF-ß1 and its binding partners during restoration of a neutral pH. Plasma should be used for measuring TGF-ß1 in blood. Because serum TGF-ß1 is highly significantly correlated with the platelet count, probably most of the TGF-ß1 is released by platelet degranulation.




The following articles in journals at HighWire Press have cited this article:


Home page
Circ. Res.Home page
J. Du, J. Xie, Z. Zhang, H. Tsujikawa, D. Fusco, D. Silverman, B. Liang, and L. Yue
TRPM7-Mediated Ca2+ Signals Confer Fibrogenesis in Human Atrial Fibrillation
Circ. Res., March 19, 2010; 106(5): 992 - 1003.
[Abstract] [Full Text] [PDF]


Home page
J Bone Joint Surg BrHome page
H. Tohyama, K. Yasuda, H. Uchida, and J. Nishihira
The responses of extrinsic fibroblasts infiltrating the devitalised patellar tendon to IL-1{beta} are different from those of normal tendon fibroblasts
J Bone Joint Surg Br, September 1, 2007; 89-B(9): 1261 - 1267.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. J. Grainger
TGF-{beta} and atherosclerosis in man
Cardiovasc Res, May 1, 2007; 74(2): 213 - 222.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
A M Hammad, H M Youssef, and M M El-Arman
Transforming growth factor beta 1 in children with systemic lupus erythematosus: a possible relation with clinical presentation of lupus nephritis
Lupus, September 1, 2006; 15(9): 608 - 612.
[Abstract] [PDF]


Home page
IOVSHome page
T. Kawakita, E. M. Espana, H. He, R. Smiddy, J.-M. Parel, C.-Y. Liu, and S. C. G. Tseng
Preservation and Expansion of the Primate Keratocyte Phenotype by Downregulating TGF-{beta} Signaling in a Low-Calcium, Serum-Free Medium
Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1918 - 1927.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Zimmermann, J. Koenig, J. Zingsem, V. Weisbach, E. Strasser, J. Ringwald, and R. Eckstein
Effect of Specimen Anticoagulation on the Measurement of Circulating Platelet-Derived Growth Factors
Clin. Chem., December 1, 2005; 51(12): 2365 - 2368.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Kawakita, E. M. Espana, H. He, A. Hornia, L.-K. Yeh, J. Ouyang, C.-Y. Liu, and S. C. G. Tseng
Keratocan Expression of Murine Keratocytes Is Maintained on Amniotic Membrane by Down-regulating Transforming Growth Factor-{beta} Signaling
J. Biol. Chem., July 22, 2005; 280(29): 27085 - 27092.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J.-A. Gomez, X. Molero, E. Vaquero, A. Alonso, A. Salas, and J.-R. Malagelada
Vitamin E attenuates biochemical and morphological features associated with development of chronic pancreatitis
Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G162 - G169.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
T. Naito, T. Masaki, D. J. Nikolic-Paterson, C. Tanji, N. Yorioka, and N. Kohno
Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-{beta}1
Am J Physiol Renal Physiol, February 1, 2004; 286(2): F278 - F287.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
F. M. Omer, J. B. de Souza, P. H. Corran, A. A. Sultan, and E. M. Riley
Activation of Transforming Growth Factor {beta} by Malaria Parasite-derived Metalloproteinases and a Thrombospondin-like Molecule
J. Exp. Med., December 15, 2003; 198(12): 1817 - 1827.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
K. G. Hobson, M. DeWing, H. S. Ho, B. M. Wolfe, K. Cho, and D. G. Greenhalgh
Expression of Transforming Growth Factor {beta}1 in Patients With and Without Previous Abdominal Surgery
Arch Surg, November 1, 2003; 138(11): 1249 - 1252.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. Daddi, T. Suda, F. D'Ovidio, S. A. Kanaan, T. Tagawa, K. Grapperhaus, B. D. Kozower, J. H. Ritter, N. S Yew, T. Mohanakumar, et al.
Recipient intramuscular cotransfection of naked plasmid transforming growth factor {beta}1 and interleukin 10 ameliorates lung graft ischemia-reperfusion injury
J. Thorac. Cardiovasc. Surg., August 1, 2002; 124(2): 259 - 269.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Porreca, C. Di Febbo, G. Baccante, M. Di Nisio, and F. Cuccurullo
Increased transforming growth factor-beta1 circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase inhibition with pravastatin
J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1752 - 1757.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
N. YEVDOKIMOVA, N. A. WAHAB, and R. M. MASON
Thrombospondin-1 Is the Key Activator of TGF-{beta}1 in Human Mesangial Cells Exposed to High Glucose
J. Am. Soc. Nephrol., April 1, 2001; 12(4): 703 - 712.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
B. M. Coupes, S. Williams, I. S. D. Roberts, C. D. Short, and P. E. C. Brenchley
Plasma transforming growth factor {beta}1 and platelet activation: implications for studies in transplant recipients
Nephrol. Dial. Transplant., February 1, 2001; 16(2): 361 - 367.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. B. Hoying, M. Yin, R. Diebold, I. Ormsby, A. Becker, and T. Doetschman
Transforming Growth Factor beta 1 Enhances Platelet Aggregation through a Non-transcriptional Effect on the Fibrinogen Receptor
J. Biol. Chem., October 22, 1999; 274(43): 31008 - 31013.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Erren, H. Reinecke, R. Junker, M. Fobker, H. Schulte, J. O. Schurek, J. Kropf, S. Kerber, G. Breithardt, G. Assmann, et al.
Systemic Inflammatory Parameters in Patients With Atherosclerosis of the Coronary and Peripheral Arteries
Arterioscler Thromb Vasc Biol, October 1, 1999; 19(10): 2355 - 2363.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.